GI Alpha-Gal Study | MicrobiomeTrials← Back to trialsNCT06268717
GI Alpha-Gal Study
CompletedNAINTERVENTIONAL
Trial Details
Start: 2023-10-17Est. Completion: 2026-06-02
Enrollment target: 30 participants Locations- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Other microbiome trials you might be interested in
Alpha-Gal SyndromeAllergy
This is a multisite, randomized, double-blind, controlled cross-over trial with detailed characterization of participant…
Little Rock, United StatesEst. completion Oct 30, 2031
Clonal Mast Cell DiseaseKIT D816V MutationSuspected KITD816V Mutated Clonal Mast Cell Disease
This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with susp…
Birmingham, United StatesEst. completion Jul 31, 2028